Latest Distributions News

West Coast Silver has initiated a 1,500-metre diamond drilling campaign at its historically rich Elizabeth Hill Silver Project in Western Australia, aiming to unlock new high-grade mineralisation using modern exploration techniques.

HealthCo Healthcare & Wellness REIT and its partners have arranged a short-term partial rent deferral with Healthscope’s receivers to maintain hospital operations during a critical transition period.

Aspermont has reported a 6% rise in revenue and a 25% jump in net profit for the half year ending March 2025, yet its net tangible assets per share have declined and dividends remain on hold.

Global X Management (AUS) Limited has announced updated estimated distributions for three ETFs listed on the ASX AQUA Market, providing investors with fresh income expectations ahead of the May 2025 period close.

Streamplay Studio Limited has had its ASX trading suspension lifted following a significant announcement about a new agreement with a gaming platform, signaling renewed investor interest.

Streamplay’s subsidiary Noodlecake has inked a three-year licensing agreement with Amazon to adapt and distribute one of its owned games on Amazon’s gaming platform, marking a strategic expansion into a new marketplace.

Regal Partners Limited reported a stellar 2024 with a 141% jump in average funds under management to $14.4 billion and a near tripling of net profit after tax. Strategic acquisitions and offshore expansion underpin its growth trajectory.

TruScreen Group Limited has announced a capital raising initiative involving Placement and Share Purchase Plan (SPP) Options, aiming to secure approximately NZ$3 million to fund strategic growth and working capital needs. The offer, subject to shareholder approval, includes up to 80.9 million Placement Options and 55.5 million SPP Options exercisable at A$0.02.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.

TruScreen Group Limited forecasts a robust 64% increase in FY26 sales, driven by strategic market expansions and new distribution agreements. The company’s AI-enabled cervical cancer screening technology is gaining traction across emerging markets.

TruScreen Group Limited has announced a NZ$3 million capital raise to fund strategic growth initiatives across Asia and Africa, alongside repaying existing debt. The raise includes a placement and share purchase plan with free attaching options, signaling confidence in its expanding cervical cancer screening programs.